Back to search
FDAFDA · Food and drugs·Recall number D-0641-2026

Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc (equivalent to 400 units), Neomycin Sulfate 5 mg, Polymixin B 5000 units, 0.9g packets, 144 packets per box, 130g, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 1 03 52410 30253 1.

Published June 24, 2026 · Recall initiated: June 2, 2026

Summary

FDA records drug Class II recall D-0641-2026, published June 24, 2026 and initiated June 2, 2026. Recalling firm: Dabur India Limited; Status: Ongoing; Reported quantity: 3006 tubes; Lot: Lot# 011, 014, 015, 016, 017, 018, 019, 020, 021, 022, 026, Within Expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; deficiencies observed during FDA inspection

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dabur India Limited
Distributor
US Nationwide.
Lot
Lot# 011, 014, 015, 016, 017, 018, 019, 020, 021, 022, 026, Within Expiry.
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc (equivalent to 400 units), Neomycin Sulfate 5 mg, Polymixin B 5000 units, 0.9g packets, 144 packets per box, 130g, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 1 03 52410 30253 1. recalled?

Yes. FDA published recall D-0641-2026 on June 24, 2026. Reported hazard: CGMP Deviations; deficiencies observed during FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail